56.7
Sara Dar
Brigham and Women's Hospital, Harvard University
Sara Dar's research contributions span multiple fields, including cancer treatment, neuroscience, and psychiatry. In the realm of oncology, studies focused on combination therapies for metastatic breast cancer (h3b-6545 with palbociclib) and myeloid neoplasms (H3B-8800 oral modulator), demonstrating potential benefits for patients. In neuroscience, research investigated abnormal semantic processing in schizophrenia (threat words associated with excitement and hostility) and explored the therapeutic efficacy of selective serotonin reuptake inhibitors for obsessive-compulsive disorder in adolescents and children. Additionally, Dar's work examined the effectiveness of adding psychotherapy to naltrexone treatment for alcohol use disorder and th17 inhibitors for psoriatic arthritis, shedding light on promising treatments for these conditions.